Alzheimer’s immunotherapy boosted by AbbVie deal – Financial Times
Financial Times |
Alzheimer's immunotherapy boosted by AbbVie deal
Financial Times AbbVie has signed a deal with a biotech company to develop medicines that encourage the immune system to fight Alzheimer's, as the drugmaker seeks to replicate an approach that has proven successful in treating cancer. The Chicago-based … A company that's taking a new approach to tackling Alzheimer's just landed a $225 million endorsement |
